Literature DB >> 8773996

Technical note--approach to myocardial perfusion with echo planar imaging.

J F Debatin, G C McKinnon, G K von Schulthess.   

Abstract

PURPOSE: To evaluate the feasibility of MRI-based myocardial first-pass contrast perfusion imaging with a multi-shot echo planar imaging (EPI) technique. SUBJECTS AND METHODS: A non-sequential (ECG-triggered) gradient echo two-shot EPI acquisition strategy capable of covering the entire heart in contiguous 10-mm sections every two cardiac cycles with an in-plane resolution of 1.56 X 1.56 mm was implemented on a 1.5-T Signa Advantage Scanner equipped with prototype hardware for non-resonant EPI in the transverse plane. The heart of a single volunteer was studied prior to and following the intravenous bolus application of a paramagnetic contrast agent (Gd-DOTA, 0.2 mmol/kg).
RESULTS: Twelve contiguous transaxial 10-mm EPI images were obtained every two RR intervals for a total of 40 s. The myocardial contrast perfusion study was technically adequate. Contrast caused a signal loss of 87% in the right and 67% in the left ventricle and 59% in the myocardium.
CONCLUSION: First-pass myocardial perfusion imaging with a gradient echo, two-shot echo planar imaging strategy is feasible.

Entities:  

Mesh:

Year:  1996        PMID: 8773996     DOI: 10.1007/bf01759774

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  11 in total

1.  Instant images of the human heart using a new, whole-body MR imaging system.

Authors:  R R Rzedzian; I L Pykett
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

2.  Echo-planar MR imaging of normal and ischemic myocardium with gadodiamide injection.

Authors:  M F Wendland; M Saeed; T Masui; N Derugin; M E Moseley; C B Higgins
Journal:  Radiology       Date:  1993-02       Impact factor: 11.105

3.  Normal heart: evaluation with echo-planar MR imaging.

Authors:  C P Davis; G C McKinnon; J F Debatin; D Wetter; A C Eichenberger; S Duewell; G K von Schulthess
Journal:  Radiology       Date:  1994-06       Impact factor: 11.105

4.  Ultrafast interleaved gradient-echo-planar imaging on a standard scanner.

Authors:  G C McKinnon
Journal:  Magn Reson Med       Date:  1993-11       Impact factor: 4.668

5.  Cardiac echo-planar MR imaging: comparison of single- and multiple-shot techniques.

Authors:  D R Wetter; G C McKinnon; J F Debatin; G K von Schulthess
Journal:  Radiology       Date:  1995-03       Impact factor: 11.105

6.  Measurement of stroke volume and cardiac output within a single breath hold with echo-planar MR imaging.

Authors:  G J Hunter; L M Hamberg; R M Weisskoff; E F Halpern; T J Brady
Journal:  J Magn Reson Imaging       Date:  1994 Jan-Feb       Impact factor: 4.813

7.  Contrast-enhanced echo-planar MR imaging of myocardial perfusion: preliminary study in humans.

Authors:  R R Edelman; W Li
Journal:  Radiology       Date:  1994-03       Impact factor: 11.105

8.  First pass of an MR susceptibility contrast agent through normal and ischemic heart: gradient-recalled echo-planar imaging.

Authors:  M F Wendland; M Saeed; T Masui; N Derugin; C B Higgins
Journal:  J Magn Reson Imaging       Date:  1993 Sep-Oct       Impact factor: 4.813

9.  First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease.

Authors:  W J Manning; D J Atkinson; W Grossman; S Paulin; R R Edelman
Journal:  J Am Coll Cardiol       Date:  1991-10       Impact factor: 24.094

10.  Ischemic heart disease: assessment with gadolinium-enhanced ultrafast MR imaging and dipyridamole stress.

Authors:  A C Eichenberger; E Schuiki; V D Köchli; F W Amann; G C McKinnon; G K von Schulthess
Journal:  J Magn Reson Imaging       Date:  1994 May-Jun       Impact factor: 4.813

View more
  1 in total

1.  Myocardial perfusion MRI with an undersampled 3D stack-of-stars sequence.

Authors:  Liyong Chen; Ganesh Adluru; Matthias C Schabel; Chris J McGann; Edward V R Dibella
Journal:  Med Phys       Date:  2012-08       Impact factor: 4.071

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.